tiprankstipranks
Advertisement
Advertisement

MGTX Stock Latest News

MeiraGTx reports Q1 EPS (57c), consensus (45c)
The FlyMeiraGTx reports Q1 EPS (57c), consensus (45c)
7d ago
MGTX
FDA Commissioner Marty Makary resigns
PremiumThe Fly
FDA Commissioner Marty Makary resigns
9d ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
9d ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
10d ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
10d ago
DYN
RNA
MeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
PremiumCompany AnnouncementsMeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
28d ago
8K
MGTX
MeiraGTx price target raised to $30 from $26 at Piper Sandler
Premium
The Fly
MeiraGTx price target raised to $30 from $26 at Piper Sandler
30d ago
JNJ
MGTX
MeiraGTx price target raised to $24 from $16 at RBC Capital
Premium
The Fly
MeiraGTx price target raised to $24 from $16 at RBC Capital
1M ago
MGTX
MeiraGTx Announces Public Equity Offering to Fund Growth
PremiumCompany Announcements
MeiraGTx Announces Public Equity Offering to Fund Growth
1M ago
8K
MGTX
MeiraGTx announces three-year data from Phase 1 AQUAx study
PremiumThe Fly
MeiraGTx announces three-year data from Phase 1 AQUAx study
1M ago
MGTX
MeiraGTx announces acquisition of bota-vec for treatment of XLRP
PremiumThe Fly
MeiraGTx announces acquisition of bota-vec for treatment of XLRP
1M ago
JNJ
MGTX
MeiraGTx Reacquires Bota-Vec Rights, Advances XLRP Program
PremiumCompany Announcements
MeiraGTx Reacquires Bota-Vec Rights, Advances XLRP Program
1M ago
8K
MGTX
MeiraGTx Reports Durable Phase 1 AQUAx Gene Therapy Data
PremiumCompany AnnouncementsMeiraGTx Reports Durable Phase 1 AQUAx Gene Therapy Data
1M ago
8K
MGTX
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
1M ago
DYN
RNA
MeiraGTx price target lowered to $18 from $20 at Evercore ISI
Premium
The Fly
MeiraGTx price target lowered to $18 from $20 at Evercore ISI
2M ago
MGTX
MeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
PremiumCompany Announcements
MeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
2M ago
MGTX
MeiraGTx price target lowered to $26 from $30 at Piper Sandler
PremiumThe Fly
MeiraGTx price target lowered to $26 from $30 at Piper Sandler
2M ago
MGTX
MeiraGTx price target raised to $16 from $14 at BofA
PremiumThe Fly
MeiraGTx price target raised to $16 from $14 at BofA
2M ago
MGTX
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances
PremiumCompany Announcements
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances
2M ago
8K
MGTX
MeiraGTx announces FDA breakthrough therapy designation for AAV2-hAQP1
PremiumThe FlyMeiraGTx announces FDA breakthrough therapy designation for AAV2-hAQP1
2M ago
MGTX
MGTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MGTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MGTX
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
2M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >